Alkem Labs Receives GST Order Demanding ₹2.05 Lakhs Plus Penalty & Interest
Alkem Laboratories received a GST order demanding ₹2,05,095 with ₹41,019 penalty and ₹1,35,733 interest for FY21-22. The company disputes the excess ITC availment allegation and plans to appeal. No material financial or operational impact is expected.
The total demand, penalty, and interest amount to approximately ₹3.82 lakhs, which is very small relative to Alkem Laboratories' overall revenue and operations, and the company explicitly states there is no material impact.
The company received a GST order with a demand, penalty, and interest, which is a negative development. However, the company disputes the order and plans to appeal, and states there is no material impact, which mitigates the negativity.
Alkem Laboratories Limited has received an order from the State Tax Officer, Taxpayer Services Circle, Thrippunithura Ernakulam, Kerala, concerning the Goods and Services Tax Act, 2017. The order pertains to the financial year 2021-22 and demands GST amounting to ₹2,05,095/-, along with a penalty of ₹41,019/- and applicable interest of ₹1,35,733/-.
The company has been notified that the demand order primarily alleges excess availment of Input Tax Credit (ITC). Alkem Laboratories Limited has stated that it does not agree with the demand order and intends to contest the same by filing an appeal.
The order was received by the company on December 24th, 2025. Alkem Laboratories Limited has emphasized that there is no material impact on its financial, operational, or other activities that can be quantified in monetary terms. The company has also made the information available on its website, www.alkemlabs.com.
What to do with a filing like this
Alkem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alkem Laboratories Limited. Read the original for the full detail.